Englebert Financial Advisers, LLC filed a Form 13F-HR with the Securities and Exchange Commission on October 20, 2026, disclosing its equity securities holdings as of September 30, 2026. The filing details the firm's portfolio of 62 positions, managed by CCO Jamie Englebert.
The portfolio is diversified across various sectors, with notable positions in large-cap technology and healthcare companies. Apple Inc. is the largest holding, with 4,943 shares. Other major holdings include Broadcom Inc. with 5,993 shares, Microsoft Corporation with 2,683 shares, and Medtronic plc with 6,541 shares. The firm also holds significant stakes in Johnson & Johnson, AbbVie Inc., and Eli Lilly & Co.
In addition to individual stocks, the portfolio includes a substantial allocation to exchange-traded funds (ETFs). The Vanguard S&P 500 ETF Trust is held with 4,209 shares, and the Vanguard Total Stock Market ETF is held with 3,280 shares. The firm also holds several specialized ETFs, including the Vanguard International Equity Index Fund All-World ex US and the Vanguard Short-Term Corporate Bond ETF.
The filing lists a total of 62 positions, with the smallest holding being Vertex Pharmaceuticals Inc., which comprises 428 shares. The largest position by number of shares is the Janus Detroit Strategic Trust HENDERSON MTG ETF, which holds 22,829,0 shares.
